CareDx to Participate in Upcoming Investor Conferences

Thursday, November 2, 2017 1:01 PM UTC

BRISBANE, Calif., Nov. 02, 2017 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Peter Maag, PhD., Chief Executive Officer, and Michael Bell, Chief Financial Officer, will be participating in three upcoming investor conferences.

Craig-Hallum Alpha Select Conference in New York City

Peter Maag will present on Thursday, November 16^th at 5:40 am PT/8:40 am ET

29^th Annual Piper Jaffray Healthcare Conference in New York City

Peter Maag will present on Tuesday, November 28^th at 11:30 am PT/2:30 pm ET

Global Mizuho Investor Conference in New York City

Peter Maag and Michael Bell will host investor meetings on Monday and Tuesday, December 4^th and 5^th.

Live audio webcasts of the Craig-Hallum Alpha Select Conference and the 29^th Annual Piper Jaffray Healthcare Conference will be available online from the investor relations section of the CareDx website at http://investors.caredxinc.com/. The webcast replay of the presentation will be available approximately one hour following the conclusion of the live presentation and will be available on the Company’s website for 90 days. Due to the one-on-one only format of the Global Mizuho Investor Conferences, no webcast will be available for this event.

About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products across the transplant testing continuum, including AlloMap® and AlloSure™ for post-transplant surveillance and Olerup SSP®, Olerup QTYPE®, and Olerup SBT™ for pre-transplant HLA testing.

For more information, please visit: www.CareDx.com.

CONTACTS:

CareDx, Inc.
Sasha King
Chief Commercial Officer
415-287-2393
[email protected]

Investor Relations
David Clair
Integrated Corporate Relations, Inc.
646-277-1266
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

CareDx to Participate in Upcoming Investor Conferences

Editor's Picks

Welcome to EconoTimes